Including information about these new approaches, such as α-synuclein seed amplification assays in either the blood or CSF, would enhance the diagnostic section and highlight the cutting-edge research being conducted to improve the early detection and management of Parkinson's disease [72]. This evidence concerns the gene SNCA and Parkinson disease.